The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, will highlight 21 promising research projects – including gene therapies, stem cell treatments, and clinical trials – during its 21 for 21 Webinar. This webinar on June 21, 2021, at 7:00 p.m. ET, is free for eye care professionals and will include a Q & A session.
Last year, 2020, was to be a monumental year for eye and vision organizations around the world, but the pandemic happened and drastically altered plans for virtually all initiatives, events, and celebrations. Delays and shutdowns of lab research studies and clinical trials for emerging therapies were especially upsetting for doctors, scientists, and the patients they are working so hard to help. But in 2021, we now see the light at the end of the tunnel.
Presenters will include the Foundation’s Ben Shaberman, senior director of scientific outreach, and Michelle Glaze, associate director of professional outreach. Special guest Caesar Luo, MD, Bay Area Retina, will provide an overview of the Foundation’s no-cost genetic testing program.
The interactive webinar is appropriate for all eye care professionals, including retinal specialists, ophthalmologists, optometrists, rehabilitation professionals, occupational therapists, and orientation and mobility instructors.
Register for the 21 for 21 Webinar here.
About the Foundation Fighting Blindness
Established in 1971, the Foundation Fighting Blindness is the world’s leading private funding source for retinal degenerative disease research. The Foundation has raised more than $816 million toward its mission of accelerating research for preventing, treating, and curing blindness caused by the entire spectrum of blinding retinal diseases including: retinitis pigmentosa, macular degeneration, and Usher syndrome. Visit FightingBlindness.org for more information.